Zentalis Pharmaceuticals

Zentalis Pharmaceuticals

Clinical-stage biopharmaceutical company focused on developing clinically differentiated, novel small molecule therapeutics. Learn more

Launch date
Employees
Market cap
CAD314m
Enterprise valuation
CAD320m (Public information from Sep 2024)
New York City New York (HQ)
Authorizing premium user...